Potential prognostic value of miRNAs as biomarker for progression and recurrence after nephrectomy in renal cell carcinoma: a literature review
| Autor: | Daniela Fasanella, Michele Marchioni, Alessio Antonaci, Matteo Ferro, Francesco Esperto, Luigi Schips, Roberto M Scarpa |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Oncology
medicine.medical_specialty medicine.medical_treatment Clinical Biochemistry Population Medicine (miscellaneous) Nephrectomy Renal cell carcinoma Internal medicine medicine Biomarkers Tumor Humans education Carcinoma Renal Cell education.field_of_study business.industry Health Policy Biochemistry (medical) Hazard ratio Public Health Environmental and Occupational Health Area under the curve medicine.disease Prognosis Confidence interval Kidney Neoplasms MicroRNAs Systematic review Biomarker (medicine) business |
| Zdroj: | Diagnosis (Berlin, Germany)References. 9(2) |
| ISSN: | 2194-802X |
| Popis: | Objectives We provide a systematic literature review on tissue miRNAs in patients with RCC to evaluate and summarize their usefulness as prognostic markers. We undertook a systematic search for articles in English using the PubMed-Medline database from January 2010 to December 2020. Studies were identified and selected according to the PRISMA criteria and the PICO methodology. The population consisted of RCC patients undergoing nephrectomy and the main outcome of interest was recurrence-free survival (RFS). Only studies providing hazard ratios (HRs) from multivariate or univariate analyzes with corresponding 95% confidence intervals (CI) and/or area under the curve (AUC) were considered. Content All nine included studies (1,541 patients) analyzed the relationship between tissue miRNA expression levels (up or downregulated) and RFS. Some of these found that the methylation status of miR-9-1, miR-9-3 and miR-124 was associated with a high risk of relapse. Moreover, miR-200b overexpression was associated with OS. MiR-210 overexpression indicated a shorter OS than those who were miR-210 negative. Finally, patients with high miR-125b expression had shorter cancer-specific survival (CSS) than those with low expression; similarly, patients with low miR-126 expression also had shorter CSS time. Summary and outlook Several studies tested the usefulness of specific miRNAs to predict RCC recurrence. Some of them showed a fair accuracy and strong relationship between specific miRNA over or under-expression and survival outcomes. However, results from these studies are preliminary and miRNAs use in routine clinical practice is still far to come. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|